Sonosite To Participate In WBBA Invest Northwest CEO And Investor Forum

BOTHELL, WA - March 13, 2007 - SonoSite, Inc. (Nasdaq: SONO), the world leader in hand-carried ultrasound, today announced that the company will present at the Washington Biotechnology and Biomedical Association (WBBA) 2007 Invest Northwest CEO and Investor Forum being held at the Bell Harbor Conference Center in Seattle from March 20 - 21.

Kevin Goodwin, President and CEO, will participate in the panel, "The Imaging Industry in the Northwest and Beyond," on March 21 from 10:15 - 11:10 am. Anne Bugge, Vice President, Corporate Affairs will present during the Investor Forum on March 20 from
2:00 - 2:20 pm.

An audio webcast of the investor presentation can be accessed via the "Investors" Section of SonoSite's website at ir.sonosite.com. The webcast will be available beginning March 21, 2007 and will remain posted for 30 days.

About SonoSite
SonoSite, Inc. (www.sonosite.com) is the innovator and world leader in hand-carried ultrasound. Headquartered near Seattle, the company is represented by eight subsidiaries and a global distribution network in over 90 countries. SonoSite's small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high performance ultrasound to the point of patient care. The company employs approximately 550 people worldwide.